Sreekanth Kokkonda

Title: Sreekanth Kokkonda: Innovator in Anticancer Research

Introduction

Sreekanth Kokkonda is a notable inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of medicinal chemistry, particularly in the development of potential anticancer agents. With a total of 3 patents to his name, Kokkonda is recognized for his innovative approaches to cancer treatment.

Latest Patents

Kokkonda's latest patents include groundbreaking work on Cinnamido-pyrrolo[2,1-C][1,4]benzodiazepines as potential anticancer agents. This invention provides a compound of general formulae (8a-i), (11a-i), (14a-i), and (17a-i), which are useful as potential antitumor agents against human cancer cell lines. Additionally, he has developed a process for the preparation of these compounds. Another significant patent involves the synthesis and in vitro anticancer activity of novel pyrrolo[2,1-c][1,4]benzodiazepine derivatives with dithiocarbamate side chains. This invention also includes a process for the preparation of these new derivatives.

Career Highlights

Sreekanth Kokkonda is affiliated with the Council of Scientific and Industrial Research, where he conducts his research. His work focuses on the synthesis of novel compounds that can potentially lead to effective cancer treatments. His dedication to research and innovation has positioned him as a key figure in his field.

Collaborations

Kokkonda has collaborated with notable colleagues, including Kamal Ahmed and Balakishan Gorre. These collaborations have further enhanced his research capabilities and contributed to the advancement of his projects.

Conclusion

Sreekanth Kokkonda is a prominent inventor whose work in anticancer research is paving the way for new therapeutic options. His innovative patents and collaborations reflect his commitment to improving cancer treatment methodologies.